Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
University of Washington